GILENYA

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: fd48c3e93363bb60
Drug Approval Canada Name: GILENYA
Product Name: GILENYA
Status: Marketed
Status Date: 2019-01-03
Original Market Date: 2019-01-03
Din: 02482533
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.16
Atc Original: L04AE01 FINGOLIMOD
Atc Name: l 04 ae 01
Aig Number: 0152886002
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE)

0.25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fd48c3e93363bb60

Type

Standard